Insight Molecular Diagnostics Inc. (IMDX) Operating income 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual operating income history from SEC filings — each fiscal year as reported.
-$51.1MFY2025 · since FY2016: -$11.1M → -$51.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.1M | +16.2% |
| FY2024 | -$61.0M | -142.8% |
| FY2023 | -$25.1M | -39.7% |
| FY2022 | -$18.0M | +66.5% |
| FY2021 | -$53.7M | -80.8% |
| FY2020 | -$29.7M | -33.6% |
| FY2019 | -$22.2M | -46.3% |
| FY2018 | -$15.2M | +19.3% |
| FY2017 | -$18.8M | -69.2% |
| FY2016 | -$11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMDX financial trends
IMDX RevenueIMDX Net incomeIMDX Net marginIMDX Gross profitIMDX Gross marginIMDX Operating marginIMDX Operating cash flowIMDX Free cash flowIMDX Capital expendituresIMDX Return on equityIMDX Stock buybacksIMDX Dividends paidIMDX Total assetsIMDX Total liabilitiesIMDX Shareholders’ equityIMDX overview →